AP
MNTA

Advisor Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Advisor Partners’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,046
Closed -$212K – 776
2020
Q3 		$212K Buy
+4,046
New +$167K 0.02% 611

Advisor Partners's MNTA Position: Q4 2020 in Review

Advisor Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,046 shares — an estimated $212K sold.

Advisor Partners first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $212K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Advisor Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Advisor Partners sold 4,046 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $212K.
  • Advisor Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Advisor Partners's Momenta Pharmaceuticals, Inc. position peaked at $212K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Advisor Partners's 13F filing for Q4 2020, filed 12 Feb 2021.